Proteus Digital Health is a pharmaceutical-based industry that makes digital medicines generally used in various behavioral, physiological, and treatments. They have a Specialty in Digital Medicine.
Proteus Digital Health uses modern technology products and services, including HTML5, which is the most updated, Google Analytics for their analytical task, and jQuery as a programing language, according to G2 Stack.
They also actively use 22 technologies for their website, according to BuiltWith. They also work for compatibility for all devices, as their clients can use them without issues.
Proteus Digital Health
Proteus Digital Health is a pioneering industry, services, and data system supported by digital medicines with wearable, mobile, and cloud computing sensors. It’s a technology-based medication help service.
The physician on their data records analysis for the treatment of the patient. They allow patients to control their health and more productively cooperate with caregivers and physicians.
They are regularly establishing new technology-oriented business models. Proteus has CE certification in Europe and FDA clearance for its market activities within the U.S. for its wearable and Ingestible Sensor™ devices. Proteus Digital Health’s head office is in Redwood City, Calif. It is a private industry funded by Carlyle, Essex Woodlands, Kaiser Permanente, Medtronic, Novartis, Otsuka, Oracle, ON Semiconductor, and other investors.
Their Services
Proteus is creating a replacement category of pharmaceuticals: Digital Medicines. Digital Medicines are devices by which the physician can proceed with his treatment and record the physiological response, which can help with data analysis and the cure rate of the patient.
Digital Medicine aims to encourage patients and their families, make physicians and health systems more productive in handling risk, and confirm that results are finally gained.
One-third to a minimum of one-half of patients prescribed courses of medication won’t continue with their treatment, leading to poor outcomes and avoidable hospitalizations. Whether this is often because of unpleasant side effects or simply a struggle to need the right drugs at the right times, the fact remains that shoddy medication adherence costs the healthcare system within the US alone an estimated £290bn a year.
Proteus Digital Health is working to develop smart pills and drugs with sensors inside and record medication effects. Proteus’ ingestible sensors transmit a symbol to a patch worn on the torso once they reach the stomach, sending a digital record to a patient’s mobile. With permission, the physician and the caregiver can monitor the patient via the Proteus cloud.
In theory, smart pills like these won’t only help patients track if they’ve taken their provided medication properly but will help them cooperate with their physician to conduct their planned treatment. The hope is to provide additional clarity to inform decision-making for physicians and their patients.
For better or worse, patients with cancer or infectious diseases tend to be monitored far more closely by their medical aid teams than people with schizophrenia and have more complex medication regimens.
Chemotherapy can often use alternative dosing schedules, which patients struggle to stay to as it’s hard for them to remain up with all the changes. There’s arguably far more scope for smart pills to shine in incidences like these than through Ability, which is typically administered once every day simultaneously.
Smart pills are such a smart medication procedure invented by Proteus. The Proteus cloud is a wonderful technology, but it is used only for some specific cases as the physicians don’t have much time to review the data.
Terms and Conditions of Proteus Health
Proteus Digital Health, Inc. announced its outcomes-based initiative with the state of Tennessee’s Medicaid program, TennCare. Proteus’ digital medicines can help backward populations. The collaboration with TennCare encourages patients to go for the treatment of hepatitis C and get a cure through improved medication performance and positive relations with their responsive teams.
In terms of this contract, Only TennCare payment will be received by the Proteus if they complete the therapy session successfully using the digital medication process.
The patient and the providers need not pay any additional charges. Proteus is currently enrolling healthcare organizations in Tennessee to participate in the initiative.
In the COVID-19 pandemic and social distancing, managing the system with digital devices like Proteus Discover is vital in improving the treatment system. Hepatitis C may be curable with proper treatment and full-session therapy.
However, social factors may challenge people to take care of or be adherent to an entire course of therapy. They are eager to support their members and providers interested in using Proteus’ digital medicines as a tool to increase successful completion of hepatitis C treatment.”
Proteus also have patient consultancy experts to provide various research and initiative.
Director of the American Liver Foundation’s Mid-South Division, Dr. Teresa Davidson, shared “There are many wrong ideas regarding treatment procedure criteria, which hampered the patient access to stress. Proteus’ initiatives are well structured in various those concerns, and the patient is getting benefit from it in the state, and possibly the country.”
Proteus member and Former Surgeon General Dr. Regina Benjamin stated-Proteus collaborate with TennCareteam to provide effective opportunities for expensive medical treatment for low and middle-income families.
This might improve outcomes and reduce future costs. The most exciting thing is that with pre-authorizations, Proteus Discover approves more patients’ treatment plans for an actual cure. I anticipate seeing this model expand to more Medicaid programs across the country.”
Responsibilities of Proteus Health
Proteus Digital Health is a technology-based industry that provides medication support services.
The service includes drugs that are co-encapsulated at a specialty pharmacy with an ingestible sensor enabling them to talk once they’re taken; a wearable patch that detects ingested medicines and measures physiologic response; applications that support patient self-care and physician decision-making; and data analytics to serve the wants of doctors, pharmacists, health systems and payers.
Proteus Discover’s concern is encouraging patients, and proper productive remote care treatment using telehealth tools support, ensuring healthcare services are reliable and trustworthy by reducing the total cost of medication. You can also check their website for further information.
Their Detail Information in Brief:
- Legal Name Proteus Digital Health, Inc.
- Address: Redwood City, California, us,
- Company size: 251-500 employees
- Founded: 2001
- Founders: Andrew Thompson, George Savage, Mark Zdeblick
- Industry: Pharmaceuticals
- Specialties: Digital Medicine
- Operating Status: Active
- Type: Private
- Last Funding Type Venture: Series Unknown
- Hub Tags: Unicorn
- Company Type: For Profit
- Number of Exits: 1
- Website: www.proteus.com
- Contact Email: [email protected]
- Phone Number: (650)632-4031
Proteus owns 600 issued patents that protect its enabling technologies and regulatory clearances within the U.S., European Union, and China. Digital Health is founded by investors for both profit and to provide services.
You May Also Like: